MHRA approves imlunestrant tosylate as new breast cancer treatment

Oral therapy authorised for ER‑positive, HER2‑negative metastatic disease with ESR1 mutations

Microplastics found in 90% of prostate cancer tumors, study reveals

Researchers have detected microplastics in nearly all prostate cancer tumors examined in a new study. Tumor tissue contained […]

PROMETHAZINE HYDROCHLORIDE tablet [Amneal Pharmaceuticals of New York LLC]

Updated Date: Tue, 17 Feb 2026 00:00:00 EST

HAPEE FRESH AND COOL WHITE 150 (sodium monofluorophosphate) gel, dentifrice HAPEE EXPLOSIVE MENTHOL RED 150 (sodium monofluorophosphate) gel, dentifrice HAPEE FRESH AND COOL WHITE 100 (sodium monofluorophosphate) gel, dentifrice HAPEE GUMTECT GUM CARE (sodium monofluorophosphate) gel, dentifrice HAPEE GUMTECT SENSITIVE 100 (sodium monofluorophosphate) gel, dentifrice HAPEE FRESH GREEN OUTBURST 100 (sodium monofluorophosphate) gel, dentifrice HAPEE FRESH GREEN OUTBURST 150 (sodium monofluorophosphate) gel, dentifrice HAPEE OUTRAGEOUS BLUE CHILL 150 (sodium monofluorophosphate) gel, dentifrice [LAMOIYAN CORPORATION]

Updated Date: Tue, 17 Feb 2026 00:00:00 EST

YEZTUGO (lenacapavir sodium) tablet, film coated YEZTUGO (lenacapavir sodium) kit [Gilead Sciences, Inc.]

Updated Date: Tue, 17 Feb 2026 00:00:00 EST

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX EXTENDED-RELEASE (hydrocodone polistirex and chlorpheniramine polistirex) suspension, extended release [Cranbury Pharmaceuticals, LLC]

Updated Date: Tue, 17 Feb 2026 00:00:00 EST

Eliminating female genital mutilation by 2030

Global efforts to eliminate female genital mutilation (FGM) stand at a crossroads, with uneven progress, commitments increasingly tested,12 […]

CONSORT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and impact of paediatric randomised trials

Summary pointsPaediatric randomised controlled trials (RCTs) provide critical evidence that informs healthcare interventions and improves outcomes for newborns, […]

ACD440 granted orphan drug status in the EU

Erythromelalgia treatment gains regulatory support following EMA decision

ViiV Healthcare data show lower rates of steatotic liver disease after switching to Dovato

PASO DOBLE sub‑analysis indicates metabolic differences between 2‑drug and 3‑drug HIV regimens